Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Ketamine effects on anxiety and fear-related behaviors: Current literature evidence and new findings

Texto completo
Autor(es):
Silote, Gabriela P. [1, 2, 3] ; de Oliveira, Sabrina F. S. [4] ; Ribeiro, Deidiane E. [2] ; Machado, Mayara S. [4] ; Andreatini, Roberto [5] ; Joca, Samia R. L. [6, 2] ; Beijamini, Vanessa [7, 4, 3]
Número total de Autores: 7
Afiliação do(s) autor(es):
[1] Aarhus Univ, Dept Clin Med, TNU, Aarhus - Denmark
[2] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Biomol Sci, Ribeirao Preto, SP - Brazil
[3] Univ Fed Espirito Santo, Biochem & Pharmacol Grad Program, Vitoria, ES - Brazil
[4] Univ Fed Espirito Santo, Hlth Sci Ctr, Dept Pharmaceut Sci, Vitoria, ES - Brazil
[5] Univ Fed Parana, Dept Pharmacol, Curitiba, PR - Brazil
[6] Aarhus Univ, AIAS, Aarhus - Denmark
[7] Univ Fed Espirito Santo, Hlth Sci Ctr, Pharmaceut Sci Grad Program, Vitoria, ES - Brazil
Número total de Afiliações: 7
Tipo de documento: Artigo Científico
Fonte: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY; v. 100, JUN 8 2020.
Citações Web of Science: 0
Resumo

Ketamine, a non-competitive N-methyl-D-aspartate (NMDA) receptor antagonist, presents a rapid and sustained antidepressant effect in clinical and preclinical studies. Regarding ketamine effects on anxiety, there is a widespread discordance among pre-clinical studies. To address this issue, the present study reviewed the literature (electronic database MEDLINE) to summarize the profile of ketamine effects in animal tests of anxiety/fear. We found that ketamine anxiety/fear-related effects may depend on the anxiety paradigm, schedule of ketamine administration and tested species. Moreover, there was no report of ketamine effects in animal tests of fear related to panic disorder (PD). Based on that finding, we evaluated if treatment with ketamine and another NMDA antagonist, MK-801, would induce acute and sustained (24 hours later) anxiolytic and/or panicolytic-like effects in animals exposed to the elevated T-maze (ETM). The ETM evaluates, in the same animal, conflict-evoked and fear behaviors, which are related, respectively, to generalized anxiety disorder and PD. Male Wistar rats were systemically treated with racemic ketamine (10, 30 and 80 mg/kg) or MK-801 (0.05 and 0.1 mg/kg) and tested in the ETM in the same day or 24 hours after their administration. Ketamine did not affect the behavioral tasks performed in the ETM acutely or 24 h later. MK-801 impaired inhibitory avoidance in the ETM only at 45 min post-injection, suggesting a rapid but not sustained anxiolytic-like effect. Altogether our results suggest that ketamine might have mixed effects in anxiety tests while it does not affect panic-related behaviors. (AU)

Processo FAPESP: 17/26815-1 - Investigação do envolvimento da via BDNF-TrkB no mecanismo de ação do efeito tipo-antidepressivo rápido e sustentado induzido pelo canabidiol
Beneficiário:Gabriela Pandini Silote
Linha de fomento: Bolsas no Brasil - Doutorado
Processo FAPESP: 18/12119-6 - Investigação dos mecanismos moleculares envolvidos no efeito antidepressivo rápido e sustentado induzidos pelo Canabidiol
Beneficiário:Gabriela Pandini Silote
Linha de fomento: Bolsas no Exterior - Estágio de Pesquisa - Doutorado